Clinical data have suggested that CCND2 was down-regulated in lung cancer and it was associated with lymph node metastasis, distant metastasis, and a poor prognosis (Table S3, p = 0.014, and p = 0.017, respectively). This evidence concerns the gene CCND2 and metastatic malignant neoplasm in the lymph nodes.